- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about BMY
Recent news which mentions BMY
Neurodegenerative Diseases Focused Company Goes Public Via Wilbur Ross-Backed SPAC, Joins Alzheimer's Race To Compete Biogen
January 18, 2023
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 17, 2023
January 17, 2023
From Benzinga
Tickers
BMY
From Motley Fool
Drug companies plan to raise prices on vital medicines to fund R&D, but they already spend more on shareholder returns
January 13, 2023
From MarketWatch
7 Dividend-Paying Large-Cap Stocks to Buy in January
January 13, 2023
From InvestorPlace
From Motley Fool
Is Alexandria Real Estate Equity a Buy?
January 10, 2023
From Motley Fool
5 Top Pharma Stocks of 2022 to Buy for the Long Haul
January 06, 2023
From InvestorPlace
Century Therapeutics Announces Internal Portfolio Prioritization, Analyst Views It As Incrementally Positive
January 06, 2023
From Benzinga
Looking At Bristol-Myers Squibb's Recent Unusual Options Activity
January 05, 2023
Tickers
BMY
From Benzinga
Investors Should Consider This Warren Buffett Advice in 2023
January 04, 2023
From Motley Fool
20 Recession-Proof Stocks to Buy Now for 2023
January 04, 2023
From Motley Fool
Congressman Sells Stocks At End Of 2022 And Retires From Office: Taking Profits Or Warning Sign?
January 03, 2023
From Benzinga
What 6 Analyst Ratings Have To Say About Bristol-Myers Squibb
January 03, 2023
Tickers
BMY
From Benzinga
23 Top Dividend Stocks to Buy and Hold in 2023
January 03, 2023
From Motley Fool
Is Exelixis Stock a Buy Now?
December 29, 2022
From Motley Fool
See a Recession in 2023? Stock Up on These 3 Ultra-Safe Dividend Stocks.
December 24, 2022
From Motley Fool
You Can Boost Your Passive Income With These 3 Dividend Raises
December 23, 2022
From Motley Fool
The Top Healthcare Stocks to Buy With $100
December 22, 2022
From Motley Fool
10 Top Dividend Stocks To Buy For 2023
December 20, 2022
From Motley Fool
My 3 Best Stocks of 2022 -- and Why I Think They'll Win Again in 2023
December 18, 2022
From Motley Fool
6 Stocks Warren Buffett Completely Exited in 2022
December 17, 2022
From Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
December 16, 2022
From Benzinga
2 Dividend Stocks to Buy and Hold Through 2023 and Beyond
December 15, 2022
From Motley Fool
From Benzinga
Precigen's Overnight Cell Manufacturing Technology Could Offer Advanced AML Patients The Option Of Promising CAR-T Therapy
December 08, 2022
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.